enGene Therapeutics (ENGN) Exchange Rate Effect (2023 - 2026)
enGene Therapeutics (ENGN) posted quarterly Exchange Rate Effect of $1000.0 for Q1 2026, little changed year-over-year from $1000.0 in Q1 2025, and little changed quarter-over-quarter from $1000.0 in Q1 2025.
enGene Therapeutics (ENGN) Exchange Rate Effect (2023 - 2026) Analysis & Trends
enGene Therapeutics (ENGN) has reported Exchange Rate Effect for 4 consecutive years, with $1000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect changed 0.0% year-over-year to $1000.0; the TTM figure through Apr 2026 stood at $1000.0 (changed 0.0% YoY), while the FY2025 annual figure was $1000.0, changed 0.0% from the prior year.
- Exchange Rate Effect held at $1000.0 in Q1 2026 per ENGN's latest filing, from $1000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1000.0 in Q1 2023 and bottomed at $1000.0 in Q1 2023.
- Historically, Exchange Rate Effect has averaged $1000.0 across 4 years, with a median of $1000.0 in 2023.
- On a YoY basis, Exchange Rate Effect climbed as much as 0.0% in 2024 and fell as far as 0.0% in 2024.
- enGene Therapeutics' Exchange Rate Effect stood at $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025, then changed by 0.0% to $1000.0 in 2026.
- Business Quant data shows ENGN's Exchange Rate Effect at $1000.0 in Q1 2026, $1000.0 in Q1 2025, and $1000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | enGene Therapeutics | 124.11 Mn | 124.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 1,000.00 |
| Jan 31, 2026 | 1,000.00 |
| Jan 31, 2025 | 1,000.00 |
| Jan 31, 2025 | 1,000.00 |
| Jan 31, 2024 | 1,000.00 |
| Jan 31, 2024 | 1,000.00 |
| Jan 31, 2023 | 1,000.00 |
| Jan 31, 2023 | 1,000.00 |